At the Outsourcing in Clinical Trials Conference, key opinion leaders shared predictions for workflow changes due to AI.

A new vaccines drug substance facility and R&D pilot plant, completed by the end of 2028, will create over 200 new jobs.

The funds will be used to advance Agomab’s candidates through clinical trials, including AGMB-129 for patients with ...

The California-based Lyell is expected to pay up to $30m in cash along with shares and milestone-based payments.

The Phase III ECZTEND study reported that patients treated with Adbry demonstrated long term safety and efficacy for up to ...

New research casts doubt on current advice recommending AF patients wait up to 14 days to receive anticoagulants after a ...

Dyno has formed a new research partnership with Roche on the development of AAV gene therapy vectors for neurological ...

AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new treatments for neuropsychiatric conditions.

Takeda and the Boston Medical Center (BMC) have announced a partnership aimed at decarbonisation across the healthcare ...

The opioid addiction treatment market will be worth $2.4bn by 2033, driven by diagnoses in the eight major world markets.

Experimental new therapies, regulatory changes, sustainability imperatives – biomanufacturers are navigating a changing ...

In pharma, smaller-scale AI and supervised machine learning models could provide more effective solutions than large language ...